The expression analysis revealed that patients with MSI-H CRC exhibit significantly elevated expression of both PD-L1 and PD-L2 compared to their MSS counterparts, highlighting a distinct immunological profile associated with the MSI-H subtype (Figure 3B). Here, PDCD1LG2 is linked to colorectal carcinoma.